Tachycardia-induced primate model of heart failure in cardiovascular drug discovery

Journal of Pharmacological and Toxicological Methods

Volumn 43, Issue 2, 2000, Pages 125-131

  Smith, A H ^a   Wolfgang, E A ^a   Flynn, D M ^a   Doe, C P A ^a   Knight, D R ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Congestive heart failure; Non human primate; Ventricular pacing

Indexed keywords

CARDIOVASCULAR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE TECHNOLOGY; GENETIC ANALYSIS; GENOME; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIMATE; TACHYCARDIA;

ANIMALS; CARDIOVASCULAR AGENTS; DISEASE MODELS, ANIMAL; HEART FAILURE, CONGESTIVE; MACACA FASCICULARIS; TACHYCARDIA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034527313     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(00)00099-X     Document Type: Article

References (62)

1. Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion
2. Rapid ventricular pacing in the dog: Pathophysiologic studies of heart failure
3. Characterization of a non-human primate model of drug-induced torsades de pointes
4. Neurohumoral aspects of heart failure
5. Evidence of inadequate investigation and treatment of patients with heart failure
6. Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeys
7. Antithrombotic efficacy of thrombin inhibitor L-374,087: Intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis
8. Depression of cardiac beta-adrenoreceptor responses during heart failure is independent of catecholamine levels in non-human primates
9. Relationship between cardiac dimensions and baroreceptor depression during the development of heart failure in non-human primates
10. Current research approaches to the treatment of heart failure
11. Myosin heavy chain synthesis during the progression of chronic tachycardia induced heart failure in rabbits
12. Which of our genes makes us human?
13. Population genomics: Laying the groundwork for genetic disease modeling and targeting
14. Animal models of human cardiovascular disease, heart failure and hypertrophy
15. Myocardial stunning and hibernation experimental models
16. The effects of a thyroid hormone analog on left ventricular performance and contractile and calcium cycling proteins in the baboon
17. Disparate effects of early pressure overload hypertrophy on velocity-dependent and force-dependent indices of ventricular performance in the conscious baboon
18. Effects of renin inhibition in the conscious primate Macaca fascicularis
19. The identification of contributory mechanisms for the development and progression of congestive heart failure in animal models
20. Proteomics in human disease: Cancer, heart and infectious diseases
21. Impact of genomics of therapeutic drug development
22. Nonhuman primates in research: A review of their crucial role
23. New paradigms in the treatment of heart failure and arrhythmia
24. Herpesvirus simiae (Herpes B) and SIV as zoonoses
25. Strategies for the application of functional genomics technology to biopharmaceutical drug discovery
26. Recent advances in the molecular analysis of inherited disease
27. Regression of atherosclerosis in nonhuman primates an overview
28. Behaviorally elicited heart rate reactivity and atherosclerosis in ovariectomized cynomolgus monkeys (Macaca fascicularis)
29. Evolving trends in the epidemiological factors of heart failure: Rationale for preventive strategies and comprehensive disease management
30. Nonhuman primate models for human disease
31. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications
32. Hemodynamic effects of the renin inhibitor CP-80,794 in several species
33. Genomic strategies for defining and dissecting developmental and physiological pathways
34. Effect of triiodothyronine (T3) on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass. An experimental study in baboons
35. Effects of terfenadine, astemizole and epinastine on electrocardiogram in conscious cynomolgus monkeys
36. What has the baboon to offer as a model of experimental ischemia?
37. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: Complete recovery after restoration of sinus rhythm
38. Antihypertensive drugs
39. Ventricular myocardial catecholamines in primates
40. Myocardial necrosis and QRS complex changes in the ischemia-reperfusion setting in a baboon model
41. Acute epicardial ECG parameters as quantitative predictors of infarct size at 1 week in the baboon
42. Effects of hyaluronidase on reducing myocardial infarct size in a baboon model of ischemia-reperfusion injury
43. Primates
44. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy
45. Utilization of genetically altered animals in the pharmaceutical industry
46. Genetically modified animals in pharmacological research: Future trends
47. Influence of lipoprotein(a) plasma concentration on neointimal growth in a monkey model of vascular injury
48. Innate protection of baboon myocardium: Effects of coronary artery occlusion and reperfusion
49. A novel heart failure model induced by sequential coronary artery occlusions and tachycardiac stress in awake pigs
50. Differences in myocardial stunning following coronary artery occlusion in conscious dogs, pigs, and baboons
51. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies
52. Identification of candidate genes for drug discovery by differential display
53. Psychosocial stress causes endothelial injury in cynomolgus monkeys via beta1-adrenoceptor activation
54. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine
55. Genetic significance of some common primate models in biomedical research
56. Genetics of nonhuman primates
57. Strategies for using nonhuman primates in genetic research on multifactorial diseases
58. Advantages and limitations of nonhuman primates as animal models in genetic research on complex diseases
59. Effects of calcium channel blocker on responses of blood flow, function, arrhythmias, and extent of infarction following reperfusion in conscious baboons